| 4451 |
ROLE OF ANTIOXIDANT DRUGS IN TREATMENT OF CHRONIC LUMBOSACRAL RADICULAR PAIN: A PROSPECTIVE, RANDOMIZED, CLINICAL TRIAL |
Department of Anesthesia and Intensive Care |
2017 |
| 4452 |
Role of MRI Apparent Diffusion Coefficient (ADC) Quantification in the differentiation between benign and malignant pulmonary lesions |
Department of Diagnostic Radiology |
2017 |
| 4453 |
Role of MRI Apparent Diffusion Coefficient (ADC) Quantification in the differentiation between benign and malignant pulmonary lesions |
Department of Chest Diseases |
2017 |
| 4454 |
Role of MRI Apparent Diffusion Coefficient (ADC) Quantification in the differentiation between benign and malignant pulmonary lesions |
Department of Chest Diseases |
2017 |
| 4455 |
Role of MRI Apparent Diffusion Coefficient (ADC) Quantification in the differentiation between benign and malignant pulmonary lesions |
Department of Chest Diseases |
2017 |
| 4456 |
Role of plasma miRNA155 and miRNA 197 as tumor markers for lung cancer |
Department of Clinical Pathology |
2017 |
| 4457 |
Role of plasma miRNA155 and miRNA 197 as tumor markers for lung cancer |
Department of Clinical Pathology |
2017 |
| 4458 |
Role of plasma miRNA155 and miRNA 197 as tumor markers for lung cancer |
Department of Clinical Pathology |
2017 |
| 4459 |
Role of plasma miRNA155 and miRNA 197 as tumor markers for lung cancer |
Department of Chest Diseases |
2017 |
| 4460 |
Role of plasma miRNA155 and miRNA 197 as tumor markers for lung cancer |
Department of Clinical Pathology |
2017 |